Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Almitrine MeSH Descriptor Data 2025


MeSH Heading
Almitrine
Tree Number(s)
D03.383.606.130
D03.383.931.095
Unique ID
D015765
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015765
Scope Note
A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep.
Entry Term(s)
Almitrine Bis(methanesulfonate)
Almitrine Bismesylate
Almitrine Dimesylate
Almitrine Monomesylate
Vectarion
Pharm Action
Respiratory System Agents
Registry Numbers
9A1222NBG4
0
106648-10-6
6RY6V6XM8T
Related Numbers
106648-10-6
27469-53-0
29608-49-9
6RY6V6XM8T
CAS Type 1 Name
1,3,5-Triazine-2,4-diamine, 6-(4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-N,N'-di-2-propenyl-
Previous Indexing
Analeptics (1966-1989)
Piperazines (1966-1989)
Public MeSH Note
90
History Note
90
Date Established
1990/01/01
Date of Entry
1989/05/15
Revision Date
2017/05/24
Almitrine Preferred
Vectarion Narrower
Almitrine Monomesylate Narrower
Almitrine Dimesylate Narrower
page delivered in 0.144s